229 related articles for article (PubMed ID: 26943589)
1. Accelerated geroncogenesis in hereditary breast-ovarian cancer syndrome.
Menendez JA; Folguera-Blasco N; Cuyàs E; Fernández-Arroyo S; Joven J; Alarcón T
Oncotarget; 2016 Mar; 7(11):11959-71. PubMed ID: 26943589
[TBL] [Abstract][Full Text] [Related]
2. Pathologic findings in breast, fallopian tube, and ovary specimens in non-BRCA hereditary breast and/or ovarian cancer syndromes: a study of 18 patients with deleterious germline mutations in RAD51C, BARD1, BRIP1, PALB2, MUTYH, or CHEK2.
Schoolmeester JK; Moyer AM; Goodenberger ML; Keeney GL; Carter JM; Bakkum-Gamez JN
Hum Pathol; 2017 Dec; 70():14-26. PubMed ID: 28709830
[TBL] [Abstract][Full Text] [Related]
3. Hereditary cancer-associated mutations in women diagnosed with two primary cancers: an opportunity to identify hereditary cancer syndromes after the first cancer diagnosis.
Saam J; Moyes K; Landon M; Williams K; Kaldate RR; Arnell C; Wenstrup R
Oncology; 2015; 88(4):226-33. PubMed ID: 25503195
[TBL] [Abstract][Full Text] [Related]
4. Germline BRCA1 mutation reprograms breast epithelial cell metabolism towards mitochondrial-dependent biosynthesis: evidence for metformin-based "starvation" strategies in BRCA1 carriers.
Cuyàs E; Fernández-Arroyo S; Alarcón T; Lupu R; Joven J; Menendez JA
Oncotarget; 2016 Aug; 7(33):52974-52992. PubMed ID: 27259235
[TBL] [Abstract][Full Text] [Related]
5. Occurrence of both breast and ovarian cancer in a woman is a marker for the BRCA gene mutations: a population-based study from western Sweden.
Einbeigi Z; Bergman A; Meis-Kindblom JM; Flodin A; Bjursell C; Martinsson T; Kindblom LG; Wahlström J; Wallgren A; Nordling M; Karlsson P
Fam Cancer; 2007; 6(1):35-41. PubMed ID: 16944270
[TBL] [Abstract][Full Text] [Related]
6. Analyses of p53 expression pattern and BRCA mutations in patients with double primary breast and ovarian cancer.
Bruchim I; Fishman A; Friedman E; Goldberg I; Chetrit A; Barshack I; Dekel E; Hirsh-Yechezkel G; Modan B; Kopolovic J
Int J Gynecol Cancer; 2004; 14(2):251-8. PubMed ID: 15086724
[TBL] [Abstract][Full Text] [Related]
7. Hereditary breast-ovarian cancer: clinical findings and medical management.
Marshall M; Solomon S
Plast Surg Nurs; 2007; 27(3):124-7. PubMed ID: 17901820
[TBL] [Abstract][Full Text] [Related]
8. Hereditary ovarian cancer.
Russo A; Calò V; Bruno L; Rizzo S; Bazan V; Di Fede G
Crit Rev Oncol Hematol; 2009 Jan; 69(1):28-44. PubMed ID: 18656380
[TBL] [Abstract][Full Text] [Related]
9. Tumour biological features of BRCA1-induced breast and ovarian cancer.
Jóhannsson OT; Idvall I; Anderson C; Borg A; Barkardóttir RB; Egilsson V; Olsson H
Eur J Cancer; 1997 Mar; 33(3):362-71. PubMed ID: 9155518
[TBL] [Abstract][Full Text] [Related]
10. Effect of Oophorectomy on Survival After Breast Cancer in BRCA1 and BRCA2 Mutation Carriers.
Metcalfe K; Lynch HT; Foulkes WD; Tung N; Kim-Sing C; Olopade OI; Eisen A; Rosen B; Snyder C; Gershman S; Sun P; Narod SA
JAMA Oncol; 2015 Jun; 1(3):306-13. PubMed ID: 26181175
[TBL] [Abstract][Full Text] [Related]
11. Metformin targets histone acetylation in cancer-prone epithelial cells.
Cuyàs E; Fernández-Arroyo S; Joven J; Menendez JA
Cell Cycle; 2016 Dec; 15(24):3355-3361. PubMed ID: 27792453
[TBL] [Abstract][Full Text] [Related]
12. BRCA Mutations Increase Fertility in Families at Hereditary Breast/Ovarian Cancer Risk.
Kwiatkowski F; Arbre M; Bidet Y; Laquet C; Uhrhammer N; Bignon YJ
PLoS One; 2015; 10(6):e0127363. PubMed ID: 26047126
[TBL] [Abstract][Full Text] [Related]
13. Risk of breast cancer after a diagnosis of ovarian cancer in BRCA mutation carriers: Is preventive mastectomy warranted?
McGee J; Giannakeas V; Karlan B; Lubinski J; Gronwald J; Rosen B; McLaughlin J; Risch H; Sun P; Foulkes WD; Neuhausen SL; Kotsopoulos J; Narod SA;
Gynecol Oncol; 2017 May; 145(2):346-351. PubMed ID: 28314588
[TBL] [Abstract][Full Text] [Related]
14. Absence of genomic BRCA1 and BRCA2 rearrangements in Ashkenazi breast and ovarian cancer families.
Stadler ZK; Saloustros E; Hansen NA; Schluger AE; Kauff ND; Offit K; Robson ME
Breast Cancer Res Treat; 2010 Sep; 123(2):581-5. PubMed ID: 20221693
[TBL] [Abstract][Full Text] [Related]
15. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT
Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145
[TBL] [Abstract][Full Text] [Related]
16. Ovarian surface epithelium: family history and early events in ovarian cancer.
Wong AS; Auersperg N
Reprod Biol Endocrinol; 2003 Oct; 1():70. PubMed ID: 14609432
[TBL] [Abstract][Full Text] [Related]
17. CHEK2 1100delC and Del5395bp mutations in BRCA-negative individuals from Serbian hereditary breast and ovarian cancer families.
Krivokuca A; Dobricic J; Brankovic-Magic M
J BUON; 2013; 18(3):594-600. PubMed ID: 24065469
[TBL] [Abstract][Full Text] [Related]
18. [Ovarian epithelial dysplasia: Description of a dysplasia scoring scheme].
Chene G; Dauplat J; Raoelfils I; Bignon YJ; Cayre A; Jaffeux P; Aublet-Cuvelier B; Pomel C; Penault-Llorca F
Ann Pathol; 2011 Feb; 31(1):3-10. PubMed ID: 21349382
[TBL] [Abstract][Full Text] [Related]
19. Time to incorporate germline multigene panel testing into breast and ovarian cancer patient care.
Graffeo R; Livraghi L; Pagani O; Goldhirsch A; Partridge AH; Garber JE
Breast Cancer Res Treat; 2016 Dec; 160(3):393-410. PubMed ID: 27734215
[TBL] [Abstract][Full Text] [Related]
20. Hereditary ovarian cancer.
Prat J; Ribé A; Gallardo A
Hum Pathol; 2005 Aug; 36(8):861-70. PubMed ID: 16112002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
